jump to navigation jump to main content jump to footer
Corporate Governance Voting Rights

Changes at a Glance: 
Voting Rights Notifications

Medios AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

Medios AG
Medios AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

18.07.2025 / 11:41 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Publication of acquisition or disposal in respect of own shares

1. Details of issuer
Medios AG
Heidestraße 9
10557 Berlin
Germany

2. Names of subsidiary undertakings or third persons
holding directly 3% or more shares, if different from 1.
 

3. Date on which threshold was crossed or reached
17 Jul 2025 

4. Share-position
  Share-position in % total amount of shares issued
Resulting situation 3.92 % 25,505,723
Previous publication n/a % /

5. Details
absolute in %
direct indirect (via subsidiary
or third person, Sec. 71d
para. 1 AktG)		 direct indirect (via subsidiary
or third person, Sec. 71d
para. 1 AktG)
1,000,000 3.92 % %


18.07.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Medios AG
Heidestraße 9
10557 Berlin
Germany
Internet: www.medios.group

 
End of News EQS News Service

2171750  18.07.2025 CET/CEST

Back to list

Stay Informed

Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.

Registration is free of charge and can be revoked at any time.

Click here to register

Claudia Nickolaus
Head of Investor & Public Relations   

+49 30 232 566 800   
ir@medios.group

About Medios

Specialty Pharma

People & Career

Important Notice!

We have been informed of a fake listing of a cosmetic product on the TEMU platform in which Medios is falsely named as the distributor. Unfortunately, such unauthorized product listings are repeatedly observed on unreliable platforms like TEMU.

We would like to clarify: This offer is in no way connected to Medios and is not authorized. Our legal department has been informed.

Please obtain medical products exclusively through authorized and verified sources.

If you have any further questions, please contact: ir@medios.group

Back to Top